ANTIMICROBIAL ACTIVITIES OF THIOLACTOMYCIN AGAINST GRAM-NEGATIVE ANAEROBES ASSOCIATED WITH PERIODONTAL-DISEASE

被引:19
作者
HAMADA, S
FUJIWARA, T
SHIMAUCHI, H
OGAWA, T
NISHIHARA, T
KOGA, T
NEHASHI, T
MATSUNO, T
机构
[1] Department of Oral Microbiology, Osaka University, Faculty of Dentistry, Suita-Osaka
[2] Department of Dental Research, National Institute of Health, Tokyo, Shinagawa-ku
[3] Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical, Gotemba, Shizuoka
来源
ORAL MICROBIOLOGY AND IMMUNOLOGY | 1990年 / 5卷 / 06期
关键词
anaerobic bacteria; antibiotics; periodontal disease; thiolactomycin;
D O I
10.1111/j.1399-302X.1990.tb00438.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Thiolactomycin (TLM), (4R)‐(2E, 5E)‐2,4,6‐trimethyl‐3‐hydroxy‐2,5,7‐octatriene‐4‐thiolide, purified from a culture filtrate of a strain of the Nocardia species, was examined for antimicrobial activities against more than 100 strains of oral and periodontally associated bacteria. Nine other commonly used antibiotics were also included for the test. We found that TLM exhibited strong and selective antimicrobial activities against Bacteroides gingivalis and other oral black‐pigmented Bacteroides species that may be etiologically associated with adult periodontitis. TLM also inhibited the growth of Actinobacillus actinomycetemcomitans, but did not affect the growth of oral streptococcal species and Eubacterium species. Strains of Eikenella corrodens were moderately susceptible to TLM, while Actinomyces viscosus strains were only slightly susceptible to it. Other antibiotics used for comparison showed a broad spectrum of antimicrobial activities in general. In conclusion, TLM exhibited highly selective antimicrobial activities to black‐pigmented Bacteroides species and A. actinomycetemcomitans, both of which are implicated in the pathogenesis of human periodontal disease. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:340 / 345
页数:6
相关论文
共 22 条
[1]  
Baker PJ, Evans RT, Slots J, Genco RJ, Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use, J Clin Periodontol, 12, pp. 201-208, (1985)
[2]  
Baker PJ, Slots J, Oenco RJ, Evans RT, Minimal inhibitory concentrations of various antimicrobial agents for human oral anaerobic bacteria, Antimicrob Agents Chemother, 24, pp. 420-424, (1983)
[3]  
Dzink JL, Socransky SS, Haffajee AD, The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases, J Clin Periodontol, 15, pp. 316-323, (1988)
[4]  
Forlenza SW, Newman MG, Horikoshi AL, Blachman U, Antimicrobial susceptibility of Capnocytophaga, Antimicrob Agents Chemother, 19, pp. 144-146, (1981)
[5]  
Genco RJ, Antibiotics in the treatment of human periodontal diseases, J Periodontol, 52, pp. 545-558, (1981)
[6]  
Greenwood D, What's new in anti‐anaerobe agents, Anaerobes today, pp. 179-185, (1988)
[7]  
Hoffler U, Niederau W, Pulverer G, Susceptibility of Bacterium actinomycetemcomitans to 45 antibiotics, Antimicrobial Agents and Chemotherapy, 17, pp. 943-946, (1980)
[8]  
Kaplan AH, Weber DJ, Oddone EZ, Perfect JR, Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review, Rev Infect Dis, 11, pp. 46-63, (1989)
[9]  
Krieg NR, Holt JG, Bergey's manual of systematic bacteriology, 1, pp. 558-575, (1984)
[10]  
Moore SEC, Microbiology of periodontal disease, J Periodont Res, 22, pp. 335-341, (1987)